Physician profile
Christopher Omerza
NPI 1063862712
$15,654.34
in general payments reported to CMS, 2019-2025
9 companies · $18.83 in 2025
The $18.83 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,294 · 2022: $4,427 · 2023: $534 · 2024: $8,382 · 2025: $18.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,000 · Food and Beverage: $934.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,000.00 |
| Food and Beverage | $934.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,566.45 | 2022-2024 | Da Vinci Surgical System |
| Alphatec Spine, INC | $3,195.32 | 2021-2022 | |
| Nuvasive, INC. | $715.51 | 2022-2023 | Alif, Tlif |
| Medtronic, INC. | $45.45 | 2023 | Progrip |
| Globus Medical, INC. | $36.30 | 2021-2024 | Xlif |
| Conmed Corporation | $31.25 | 2023 | Airseal, Conmed Specimen Retrieval |
| Davol INC. | $30.86 | 2024 | Phasix Mesh |
| Hologic Sales and Service, LLC | $18.83 | 2025 | Celero-12, Sertera Biopsy Device, Atec |
| Myriad Genetic Laboratories, INC. | $14.37 | 2024 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Omerza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.